JP2017503749A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017503749A5 JP2017503749A5 JP2016519779A JP2016519779A JP2017503749A5 JP 2017503749 A5 JP2017503749 A5 JP 2017503749A5 JP 2016519779 A JP2016519779 A JP 2016519779A JP 2016519779 A JP2016519779 A JP 2016519779A JP 2017503749 A5 JP2017503749 A5 JP 2017503749A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- cyclic
- acyclic
- branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361885384P | 2013-10-01 | 2013-10-01 | |
| US61/885,384 | 2013-10-01 | ||
| US201461934618P | 2014-01-31 | 2014-01-31 | |
| US61/934,618 | 2014-01-31 | ||
| PCT/US2014/058680 WO2015051030A2 (en) | 2013-10-01 | 2014-10-01 | Stabilized polypeptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017503749A JP2017503749A (ja) | 2017-02-02 |
| JP2017503749A5 true JP2017503749A5 (enExample) | 2018-08-30 |
Family
ID=52779285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016519779A Pending JP2017503749A (ja) | 2013-10-01 | 2014-10-01 | 安定化されたポリペプチドおよびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20160244494A1 (enExample) |
| EP (1) | EP3052520A4 (enExample) |
| JP (1) | JP2017503749A (enExample) |
| CN (1) | CN106103472A (enExample) |
| IL (1) | IL244810A0 (enExample) |
| WO (1) | WO2015051030A2 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192713B1 (en) | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
| US8889632B2 (en) | 2007-01-31 | 2014-11-18 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
| EP2508531B1 (en) | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
| SI2603600T1 (sl) | 2010-08-13 | 2019-04-30 | Aileron Therapeutics, Inc. | Peptidomimetični makrocikli |
| TW201806968A (zh) | 2011-10-18 | 2018-03-01 | 艾利倫治療公司 | 擬肽巨環化合物 |
| KR102112373B1 (ko) | 2012-02-15 | 2020-05-18 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드모방체 마크로사이클 |
| HK1205454A1 (en) | 2012-02-15 | 2015-12-18 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| WO2014138429A2 (en) | 2013-03-06 | 2014-09-12 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and use thereof in regulating hif1alpha |
| WO2015088990A1 (en) | 2013-12-09 | 2015-06-18 | Durect Corporation | Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same |
| BR112017005598A2 (pt) | 2014-09-24 | 2017-12-12 | Aileron Therapeutics Inc | macrociclos peptidomiméticos e usos dos mesmos |
| JP2018503595A (ja) | 2014-09-24 | 2018-02-08 | エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | ペプチド模倣大環状分子およびその製剤 |
| WO2016154058A1 (en) | 2015-03-20 | 2016-09-29 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| US10059741B2 (en) | 2015-07-01 | 2018-08-28 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| CA3043464A1 (en) | 2016-11-09 | 2018-05-17 | Ohio State Innovation Foundation | Di-sulfide containing cell penetrating peptides and methods of making and using thereof |
| US10913773B2 (en) | 2016-11-22 | 2021-02-09 | Ohio State Innovation Foundation | Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha |
| US11352394B2 (en) | 2016-11-22 | 2022-06-07 | Ohio State Innovation Foundation | Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof |
| BR112020004555A2 (pt) | 2017-09-07 | 2020-09-24 | Fog Pharmaceuticals, Inc. | agentes que modulam funções de beta-catenina e métodos dos mesmos |
| US11339192B2 (en) | 2017-10-04 | 2022-05-24 | Ohio State Innovation Foundation | Bicyclic peptidyl inhibitors |
| CN120118207A (zh) | 2017-12-15 | 2025-06-10 | 丹娜-法伯癌症研究院有限公司 | 稳定肽-介导的靶向蛋白降解 |
| US11434263B2 (en) | 2018-01-05 | 2022-09-06 | President And Fellows Of Harvard College | Stabilized polypeptides and uses thereof |
| EP3746105A4 (en) | 2018-01-29 | 2022-05-18 | Ohio State Innovation Foundation | CYCLIC PEPTIDYLIN HIBITORS OF THE CAL-PDZ-BINDING DOMAIN |
| EP3749678A1 (en) | 2018-02-07 | 2020-12-16 | Dana Farber Cancer Institute, Inc. | Cell-permeable stapled peptide modules for cellular delivery |
| WO2019165183A1 (en) | 2018-02-22 | 2019-08-29 | Entrada Therapeutics, Inc. | Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy |
| WO2019217682A1 (en) | 2018-05-09 | 2019-11-14 | Ohio State Innovation Foundation | Cyclic cell-penetrating peptides with one or more hydrophobic residues |
| US11091522B2 (en) | 2018-07-23 | 2021-08-17 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| CN121064336A (zh) * | 2018-07-31 | 2025-12-05 | 雷莫内克斯生物制药有限公司 | 多肽递送组合物 |
| AU2019326423A1 (en) | 2018-08-20 | 2021-04-08 | Fog Pharmaceuticals, Inc. | Collections of peptides, peptide agents, and methods of use thereof |
| WO2022092295A1 (ja) * | 2020-10-30 | 2022-05-05 | Ｘｅｎｏ－Ｉｎｔｅｒｆａｃｅ株式会社 | βストランド型架橋ペプチド |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2367475T3 (es) * | 1999-10-15 | 2011-11-03 | Avatar Medical, L.L.C. | Proteínas estabilizadas. |
| EP1680443B9 (en) * | 2003-11-05 | 2014-09-03 | Dana-Farber Cancer Institute, Inc. | Stabilized alpha helical peptides and uses thereof |
| EP1689863B1 (en) * | 2003-11-15 | 2014-05-28 | Polyphor Ltd. | Template fixed beta-hairpin loop mimetics and their use in phage display |
| WO2005118620A2 (en) * | 2004-05-27 | 2005-12-15 | New York University | Methods for preparing internally constraied peptides and peptidomimetics |
| WO2006069001A2 (en) * | 2004-12-20 | 2006-06-29 | Baylor College Of Medicine | Structural requirements for stat3 binding and recruitment to phosphototyrosine ligands |
| EP2508531B1 (en) * | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
| EP2356139A4 (en) * | 2008-07-23 | 2013-01-09 | Harvard College | LIGURE COMBINED POLYPEPTIDES |
| WO2011008260A2 (en) * | 2009-07-13 | 2011-01-20 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
| US20130177979A1 (en) * | 2010-06-22 | 2013-07-11 | University Of Central Florida Research Foundation, Inc. | Methods and compositions for cell permeable stat3 inhibitor |
-
2014
- 2014-10-01 US US15/026,473 patent/US20160244494A1/en not_active Abandoned
- 2014-10-01 WO PCT/US2014/058680 patent/WO2015051030A2/en not_active Ceased
- 2014-10-01 EP EP14850442.6A patent/EP3052520A4/en not_active Withdrawn
- 2014-10-01 JP JP2016519779A patent/JP2017503749A/ja active Pending
- 2014-10-01 CN CN201480065507.3A patent/CN106103472A/zh active Pending
-
2016
- 2016-03-29 IL IL244810A patent/IL244810A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7490735B2 (ja) | ジスルフィド含有細胞膜透過ペプチド並びにその製造方法及び使用方法 | |
| ES2654551T3 (es) | Anticuerpo contra el CSF-1R | |
| DK2678037T3 (en) | Branched linker for protein pharmaceutical conjugates | |
| Baumruck et al. | Chemical synthesis of membrane proteins: a model study on the influenza virus B proton channel | |
| ES2882634T3 (es) | Compuestos peptídicos y conjugados con péptidos para el tratamiento del cáncer mediante quimioterapia mediada por receptores | |
| JP2014506135A5 (enExample) | ||
| FI3354729T3 (fi) | Anti-garp-vasta-aine | |
| TW201915009A (zh) | 合成依特卡肽（Ｅｔｅｌｃａｌｃｅｔｉｄｅ）或其鹽類之方法 | |
| JP7780253B2 (ja) | ステープルペプチドの細胞内送達のためのポリペプチド接合体 | |
| EP3398957B1 (en) | Method for synthesizing etelcalcetide | |
| CN104130315B (zh) | 一种特异靶向her2蛋白的多肽 | |
| CN102510755A (zh) | 双功能钉接多肽和其用途 | |
| CN111040020B (zh) | 一种烯烃硫醚类订书肽及其制备方法与应用 | |
| ITMI20100093A1 (it) | Peptidi ciclici che legano il recettore cxcr4 e relativi usi in campo medico e diagnostico | |
| Qian et al. | Effects on polo-like kinase 1 polo-box domain binding affinities of peptides incurred by structural variation at the phosphoamino acid position | |
| Li et al. | Greener liquid-phase synthesis and the ACE inhibitory structure–activity relationship of an anti-SARS octapeptide | |
| Tung et al. | Peptide 2-formylthiophenol esters do not proceed through a Ser/Thr ligation pathway, but participate in a peptide aminolysis to enable peptide condensation and cyclization | |
| Singh et al. | Synthesis and characterization of selenium (I/II) and tellurium (IV) derivatives of amino acids | |
| US10258695B2 (en) | Protein derivatization to endow cell penetration | |
| Atkinson et al. | Development of small cyclic peptides targeting the CK2α/β interface | |
| Mandal et al. | Structure–activity studies of phosphopeptidomimetic prodrugs targeting the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3 (Stat3) | |
| WO2015125892A1 (ja) | 蛋白質の標識化合物 | |
| JP7687711B2 (ja) | ネイティブケミカルライゲーションを用いる新規フロー合成方法 | |
| JP6707783B2 (ja) | ペプチド化合物及びペプチド化合物の製造方法 | |
| WO2019072231A1 (zh) | 核磁共振显像化合物、核磁共振显像剂及应用、以及核磁共振成像方法 |